MassChallenge's Biotechnology Portfolio

Naturbeads is scaling up the technology to manufacture cellulose beads and replace plastic microbeads intentionally added to many products

Yeastime's value proposition is its innovative retrofitting ultrasound technology, which accelerates fermentation by up to 30%.

Solving global food and nutrition challenges by unleashing the true potential of microalgae.

Tympanogen is a medical technology company that develops ear, nose, and throat (ENT) devices and wound-healing therapies.

B'ZEOS offers sustainable, home compostable, and bio-digestible packaging solutions made from seaweed extracts to combat plastic pollution.

Biometry is a predictive analytics and clinical oversight to manage asthma.

Phytolon offers natural food colors in high quality at low costs.

Lymphatica Medtech is a medical device development company developing a minimally invasive solution for chronic lymphedema.

Enzymit is a bioproduction platform company based on computational protein design and ‘cell-free' enzymatic manufacturing technology

LIfT Biosciences® a rapidly emerging biotech company bringing to market a first-in-class allogeneic innate cell therapy

Regenosca develops biomaterials serving as an alternative to autologous tissue substitutes for soft tissue repair.

Microcaps develops a novel technology that enables the scalable production of precise microcapsules and microparticles.

TissueLabs is a biotechnology research company that operates a platform for creating organs and tissues in the lab.